专家：破除“懒癌”误区，推动甲状腺癌精准诊治

Core Insights - The recent "National Thyroid Cancer Prevention and Control Day" highlighted the need to address public misconceptions about thyroid cancer, particularly the belief that it is a "harmless" disease, emphasizing the importance of recognizing its risks and promoting scientific prevention and treatment [1][2] Group 1: Disease Awareness and Management - Experts advocate for the establishment of "Thyroid Cancer Prevention Day" to combat public misconceptions and promote awareness of the disease's dangers and recurrence risks [1] - Thyroid cancer is the most common malignant tumor in the head and neck region, with differentiated types like papillary and follicular cancer having a better prognosis, while highly malignant types such as medullary and undifferentiated cancers pose significant risks [1] - Patients cannot determine the malignancy type or severity based solely on nodule size or growth rate, and ultrasound has limitations in detecting small lymph node metastases, necessitating preoperative puncture or postoperative pathological results for diagnosis [1] Group 2: Postoperative Management and Treatment - Despite a generally good prognosis for thyroid cancer, a significant proportion of patients experience recurrence or metastasis due to inadequate postoperative management [2] - Differentiated thyroid cancer patients are stratified into high, medium, and low-risk categories based on pathological results, with high-risk patients requiring close monitoring and potential iodine-131 treatment to reduce recurrence risk [2] - Dynamic assessment and standardized follow-up are crucial, as some patients initially assessed as low-risk may later develop metastasis, elevating their risk to high [2] - Patients often make dangerous decisions regarding medication, such as self-adjusting dosages without medical guidance, highlighting the need for proper medication management and monitoring [2]